Tenaya Therapeutics is trading at $0.82 (-5.78%) as the stock moves lower alongside a weaker biotech tape and broader risk-off sentiment.
- The decline appears driven by sector-wide profit-taking rather than any company-specific catalysts.
- No fresh announcements or analyst actions were reported for the company for July 13, 2026.